Navi Mumbai, 28th November 2024 – Apollo Cancer Centres (ACCs), a leader in cutting-edge cancer care, has launched India’s first LungLife Screening Program for early detection of lung cancer. This groundbreaking initiative aims to combat lung cancer, which accounts for 5.9% of all cancers and 8.1% of cancer-related deaths in India. Early detection aids in better treatment outcomes and enhances the survival rate (LINK).
GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer (IARC) show lung cancer remains the leading cause of cancer death, with an estimated 1.8 million deaths (18%) in 2020. The LungLife Screening Program targets individuals who have the highest risk for lung cancer, such as: (i) people between the age group of 50 and 80 years, (ii) asymptomatic individuals (no signs or symptoms of lung cancer), (iii) individuals with a significant history of smoking, and (iv) people with a family history of lung cancer.
Early screening through low-dose computed tomography (LDCT) can aid in early detection and significantly improve survival rates. Yet, approximately 80% of high-risk individuals have never discussed screening with their healthcare providers. It is vital to enhance communication and awareness around lung cancer screening to enable early diagnosis and save lives, especially among the high-risk population.
Dr. Pavankumar Biraris, Consultant Pulmonology, Apollo Cancer Centre, Navi Mumbai, said, “Lung cancer remains one of the deadliest cancers globally, but early detection notably enhances survival chances. Through our LungLife Screening Program, we aim to identify high-risk individuals early, using advanced low-dose CT technology, which minimizes radiation exposure while maximizing diagnostic precision. This program is particularly impactful for individuals with a history of smoking, passive smoking exposure, or a family history of lung cancer. By detecting lung cancer at a treatable stage, we empower patients with better treatment outcomes and build a renewed hope for a healthier future.”
Dr. Jyoti Bajpai, Lead – Medical and Precision Oncology, Apollo Cancer Centre, Navi Mumbai, said, “The introduction of Apollo Cancer Centre’s LungLife Screening Program marks a pivotal step in addressing the alarming rise of lung cancer in India. With this comprehensive screening program, we focus on early-stage detection, where the chances of effective treatment and recovery are exponentially higher. The program leverages state-of-the-art low-dose CT scans, ensuring accurate diagnoses while prioritizing patient safety. Together, we are not just treating cancer but transforming lives through timely interventions and holistic care tailored to individual needs.”
Dr. Anil D’Cruz, Head of Oncology Department, Apollo Cancer Centre, Navi Mumbai, said, “Lung cancer is a silent threat, often detected only when it has advanced, thereby making early detection a critical intervention. With the launch of the LungLife Screening Program, Apollo Cancer Centre is revolutionizing the approach to lung cancer care. This program combines precision diagnostics with patient-focused care to detect it early, significantly improving survival rates. Our initiative demonstrates that proactive healthcare can save lives, offering patients the best chance for recovery and reinforcing our commitment to redefining excellence in cancer treatment.”
Mr. Arunesh Punetha, CEO, Western Region, Apollo Cancer Centre, Navi Mumbai, said, “We are proud to be the first in India to launch the LungLife Screening Program, a groundbreaking initiative that reflects Apollo Cancer Centre’s leadership in oncology care. Our goal is not just to save lives but to empower individuals with the knowledge and tools to take control of their health.”
Apollo Cancer Centres remains steadfast in its mission to elevate the standards of cancer care and awareness in India. With the introduction of the LungLife Screening Program, ACCs hopes to inspire nationwide action and collaboration in the fight against lung cancer.
#WinningOverCancer
About Apollo Cancer Centre
[https://apollocancercentres.com]
**THE CANCER CARE LEGACY: BREATHING HOPE INTO LIVES FOR OVER 30 YEARS**
Cancer care today means 360-degree comprehensive care, which requires commitment, expertise, and an indomitable spirit from cancer specialists. Apollo Cancer Centre has a network across India with over 390 oncologists overseeing the delivery of high-end precision oncology therapy. Our oncologists deliver world-class cancer care following an organ-based practice under competent Cancer Management Teams. This helps us deliver exemplary treatment to patients in an environment that consistently meets international standards of clinical outcomes. Today, people from 147 countries come to India for cancer treatment at Apollo Cancer Centres. With the first Pencil Beam Proton Therapy Centre in South Asia & the Middle East, Apollo Cancer Centre has all the resources needed to strengthen the battle against cancer.
For media inquiries or further information, please contact:
Ad Factor
Poulomy Dey | [email protected] | +918670400633
Watch this YouTube Video:
